Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action
- 27 November 2012
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (50) , 20732-20737
Abstract
Several studies in rodent models have shown that glycogen synthase kinase 3 β (GSK3β) plays an important role in the actions of antispychotics and mood stabilizers. Recently it was demonstrated that GSK3β through a β-arrestin2/protein kinase B (PKB or Akt)/protein phosphatase 2A (PP2A) signaling complex regulates dopamine (DA)- and lithium-sensitive behaviors and is required to mediate endophenotypes of mania and depression in rodents. We have previously shown that atypical antipsychotics antagonize DA D2 receptor (D2R)/β-arrestin2 interactions more efficaciously than G-protein–dependent signaling, whereas typical antipsychotics inhibit both pathways with similar efficacy. To elucidate the site of action of GSK3β in regulating DA- or lithium-sensitive behaviors, we generated conditional knockouts of GSK3β, where GSK3β was deleted in either DA D1- or D2-receptor–expressing neurons. We analyzed these mice for behaviors commonly used to test antipsychotic efficacy or behaviors that are sensitive to lithium treatment. Mice with deletion of GSK3β in D2 (D2GSK3β −/− ) but not D1 (D1GSK3β −/− ) neurons mimic antipsychotic action. However, haloperidol (HAL)-induced catalepsy was unchanged in either D2GSK3β −/− or D1GSK3β −/− mice compared with control mice. Interestingly, genetic stabilization of β-catenin, a downstream target of GSK3β, in D2 neurons did not affect any of the behaviors tested. Moreover, D2GSK3β −/− or D1GSK3β −/− mice showed similar responses to controls in the tail suspension test (TST) and dark–light emergence test, behaviors which were previously shown to be β-arrestin2- and GSK3β-dependent and sensitive to lithium treatment. Taken together these studies suggest that selective deletion of GSK3β but not stabilization of β-catenin in D2 neurons mimics antipsychotic action without affecting signaling pathways involved in catalepsy or certain mood-related behaviors.Keywords
This publication has 61 references indexed in Scilit:
- Discovery of β-Arrestin–Biased Dopamine D2Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic EfficacyProceedings of the National Academy of Sciences, 2011
- D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortexProceedings of the National Academy of Sciences, 2011
- Behavioral and pharmacological assessment of a potential new mouse model for maniaPhysiology & Behavior, 2011
- A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in MiceNeuropsychopharmacology, 2010
- Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviorsProceedings of the National Academy of Sciences, 2010
- A kinesin signaling complex mediates the ability of GSK-3β to affect mood-associated behaviorsProceedings of the National Academy of Sciences, 2010
- Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in miceBrain Research Bulletin, 2010
- Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychoticsProceedings of the National Academy of Sciences, 2008
- Cell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugsNature Neuroscience, 2008
- Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim testNeuropharmacology, 2008